Form 8-K - Current report:
SEC Accession No. 0001140361-21-021523
Filing Date
2021-06-21
Accepted
2021-06-21 06:01:02
Documents
1
Period of Report
2021-06-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K brhc10025804_8k.htm 8-K 24051
  Complete submission text file 0001140361-21-021523.txt   25187
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 211027025
SIC: 2834 Pharmaceutical Preparations